共 291 条
[1]
Villanueva A(2019)Hepatocellular carcinoma Reply N Engl J Med 381 1264-1273.e1
[2]
El-Serag HB(2012)Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology 142 1573-84.e1-2
[3]
Singh S(2013)Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis Clin Gastroenterol Hepatol 11 191-9
[4]
Fujii LL(2015)Emerging trends in hepatocellular carcinoma incidence and mortality Hepatology. 61 599-616
[5]
Murad MH(2018)Molecular therapies and precision medicine for hepatocellular carcinoma Nat Rev Clin Oncol 15 1124-1141
[6]
Wang Z(2019)β-catenin activation promotes immune escape and resistance to Anti-PD-1 therapy in hepatocellular carcinoma Cancer Discov. 9 2524-2529
[7]
Asrani SK(1990)Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis European J Cancer. 42 e1904197-2208
[8]
Ehman RL(2019)Recent progress in ferroptosis inducers for cancer therapy Adv Mater. 31 50-2388
[9]
et, al. B(2020)Novel insights on targeting ferroptosis in cancer therapy Biomark Res 2 98-92
[10]
Njei Y(2022)Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma J Exp Clin Cancer Res. 41 427-248